Quick Answer ACRO BIOMEDICAL CO., LTD. reported Total Revenue of $0.00 for fiscal year 2025. ACRO BIOMEDICAL CO., LTD. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $0.00 $0.00 $0.00-100.0% $658.5K-45.0% $1.20M — Net Income -$101.1K-139.1% -$42.3K+99.5% -$8.81M+44.5% -$15.87M-106.2% -$7.70M-6454.0% -$117.5K+68.3% Diluted EPS $0.00 $0.00+100.0% -$0.15+42.3% -$0.26 — — … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Shares Outstanding of 42.96 million shares for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2023 42.96M +0.0% 2022 42.96M +0.0% 2021 42.96M +0.0% 2020 42.96M +0.0% 2019 42.96M +64340.0% 2018 66,666 … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Operating Income of -$690.00 for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2023 -$690.00 +96.3% 2022 -$18.9K +71.3% 2021 -$65.7K +49.9% 2020 -$131.1K -20.4% 2019 -$108.9K -421.2% 2018 -$20.9K — Quarterly … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Stockholders Equity of $16.4 thousand for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2023 $16.4K -15.2% 2022 $19.3K -49.4% 2021 $38.2K -63.2% 2020 $103.8K -55.8% 2019 $234.9K +1235.7% 2018 -$20.7K — … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Total Assets of $76.9 thousand for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2023 $76.9K -39.8% 2022 $127.8K +232.7% 2021 $38.4K -67.6% 2020 $118.6K -52.6% 2019 $250.1K +124948.5% 2018 $200.00 — … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Cash and Equivalents of $70.6 thousand for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2023 $70.6K -42.1% 2022 $121.9K +335.4% 2021 $28.0K -76.4% 2020 $118.6K -51.2% 2019 $242.9K +121366.5% … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Diluted EPS of $0.00 per share for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2023 $0.00 — 2022 $0.00 — The most recent figure is from NP Life Sciences Health Industry … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Net Income of -$2.9 thousand for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2023 -$2.9K +84.4% 2022 -$18.9K +71.3% 2021 -$65.7K +49.9% 2020 -$131.1K -20.4% 2019 -$108.8K -421.1% 2018 -$20.9K — … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Revenue (ASC 606) of $164.6 thousand for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2023 $164.6K +61.4% 2022 $102.0K +191.5% 2021 $35.0K +133.3% 2020 $15.0K -65.1% 2019 $43.0K — … Read more
Quick Answer NP Life Sciences Health Industry Group Inc. reported Total Revenue of $164.6 thousand for fiscal year 2023. NP Life Sciences Health Industry Group Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2023 $164.6K +61.4% 2022 $102.0K +191.5% 2021 $35.0K +133.3% 2020 $15.0K -65.1% 2019 $43.0K — Quarterly Total Revenue … Read more